February 7th, 2022
Post-operative infections occur in up to 300,000 patients per year in the United States and cost the US healthcare system tens of billions of dollars a year.
Ondine Biomedical Inc. (LON: OBI), has treated the first patients in its nasal photodisinfection exploratory Phase 2 trial. The study will evaluate how effectively the...
